Validation of Newly Proposed Time to Transarterial Chemoembolization Progression in Intermediate-Stage Hepatocellular Carcinoma Cases
Article 2017 en
Authors
HI
Hirofumi Izumoto
AH
Atsushi Hiraoka
YI
Yoshihiro Ishimaru
Abstract
1 min read
In patients with reduced TTTP, especially <5 months, it might be difficult to improve prognosis with a repeated TACE procedures. In such cases, reconsideration of the therapeutic strategy might be needed when possible.
Discussion(0)
No comments yet. Be the first to comment.